Genetic variation increases risk of metabolic side effects in children on some antipsychotics

Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease. The study showed a close association with two conditions in particular: high blood pressure and elevated fasting blood sugar levels, which is a precursor to diabetes.

UK women at risk from vitamin A deficiency

Almost half of UK women could be suffering from a lack of vitamin A due to a previously undiscovered genetic variation, scientists have found.